This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 1988 May;7(5):331-9.

Aztreonam: review of the clinical experience and potential uses in pediatrics

M H Lebel¹, G H McCracken Jr

Affiliations

PMID: 3288947

Review

Aztreonam: review of the clinical experience and potential uses in pediatrics

M H Lebel et al. Pediatr Infect Dis J. 1988 May.

. 1988 May;7(5):331-9.

Authors

M H Lebel¹, G H McCracken Jr

Affiliation

¹ Department of Pediatrics, University of Texas Southwestern Medical Center, Dallas.

PMID: 3288947

No abstract available

PubMed Disclaimer

Similar articles

The use of aztreonam in pediatric patients: a review.
Bosso JA, Black PG. Bosso JA, et al. Pharmacotherapy. 1991;11(1):20-5. Pharmacotherapy. 1991. PMID: 1902290 Review.
[An Italian multicenter study on the efficacy and tolerability of aztreonam in the treatment of urinary tract infections].
Martelli A, Cortecchia V, Ventriglia L. Martelli A, et al. Clin Ter. 1988 May 15;125(3):191-201. Clin Ter. 1988. PMID: 2973940 Clinical Trial. Italian. No abstract available.
Aztreonam in gram-negative infections in children.
Sklavunu-Tsurutsoglu S, Gatzola-Karaveli M, Hitoglu-Makedu A, Paradelis AG, Tsurutsoglu G. Sklavunu-Tsurutsoglu S, et al. Chemioterapia. 1987 Jun;6(2 Suppl):415-7. Chemioterapia. 1987. PMID: 3509461 No abstract available.
[Moxalactam in pediatrics. Clinical and pharmacokinetic experience. Apropos of 37 cases].
Bégué P, Safran C, Fleurette J, Brun Y, Floret D, Monnet P. Bégué P, et al. Sem Hop. 1983 Jun 30;59(26):1972-6. Sem Hop. 1983. PMID: 6310789 French. No abstract available.
[Respiratory deterioration and allergic bronchopulmonary aspergillosis in cystic fibrosis].
Salcedo Posadas A. Salcedo Posadas A. Enferm Infecc Microbiol Clin. 2000 Jun-Jul;18(6):301-3. Enferm Infecc Microbiol Clin. 2000. PMID: 11075497 Review. Spanish. No abstract available.

See all similar articles

Cited by

Reducing Antibiotic Use for Young Children with Intussusception following Successful Air Enema Reduction.
Zhang Y, Zou W, Zhang Y, Ye W, Chen X, Liu Q, Liu H, Si C, Jia H. Zhang Y, et al. PLoS One. 2015 Nov 16;10(11):e0142999. doi: 10.1371/journal.pone.0142999. eCollection 2015. PLoS One. 2015. PMID: 26569111 Free PMC article.
Antibiotics in neonatal infections: a review.
Fanos V, Dall'Agnola A. Fanos V, et al. Drugs. 1999 Sep;58(3):405-27. doi: 10.2165/00003495-199958030-00003. Drugs. 1999. PMID: 10493270 Review.
Cystic fibrosis, pathophysiological and clinical aspects.
Neijens HJ, Sinaasappel M, de Groot R, de Jongste JC, Overbeek SE. Neijens HJ, et al. Eur J Pediatr. 1990 Aug;149(11):742-51. doi: 10.1007/BF01957271. Eur J Pediatr. 1990. PMID: 2226544 Review.
Commonly used antibacterial and antifungal agents for hospitalised paediatric patients: implications for therapy with an emphasis on clinical pharmacokinetics.
Singh J, Burr B, Stringham D, Arrieta A. Singh J, et al. Paediatr Drugs. 2001;3(10):733-61. doi: 10.2165/00128072-200103100-00003. Paediatr Drugs. 2001. PMID: 11706924 Review.
Antibacterial-induced nephrotoxicity in the newborn.
Fanos V, Cataldi L. Fanos V, et al. Drug Saf. 1999 Mar;20(3):245-67. doi: 10.2165/00002018-199920030-00005. Drug Saf. 1999. PMID: 10221854 Review.

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
Medical
- MedlinePlus Health Information